| 标题 |
Outcomes of elacestrant in patients with ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer who received prior endocrine therapy and cyclin-dependent kinase inhibitor in a real-world setting |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:G. Curigliano; M. de Laurentiis; N. Harbeck; S. Kuemmel; J. García-Sáenz; et al 出版日期:2026-09-14 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)